American Thyroid Association Announces New President-Elect and Board Members

October 17, 2013 — The American Thyroid Association (ATA) installed new President-Elect Robert C. Smallridge, M.D. and two new members to its Board of Directors, Anthony Hollenberg, M.D. and     Jacqueline Jonklaas, M.D.,  at the organization’s 83rd Annual Meeting being held October 16-20 in San Juan, Puerto Rico.

Dr. Smallridge is Professor of Medicine and former Chair, Endocrinology Division at Mayo Clinic Florida. He is Deputy Director, Mayo Clinical Cancer Center, and the Alfred D. and Audrey M. Petersen Professor in Cancer Research. A Colonel (Retired) in the U.S. Army, he served as Director, Department of Medicine at the Walter Reed Army Institute of Research, and Professor of Medicine at the Uniformed Services University of the Health Sciences, as well as Consultant in Endocrinology to the Attending Physician for the U.S. Congress and Supreme Court. Dr. Smallridge received his undergraduate degree from Yale University, and completed his medical degree at the Medical College of Virginia.

Dr. Smallridge is “proud to be part of an organization that has promoted many of the advances in research and clinical practice that have improved the care of patients with thyroid disorders.” He believes the ATA should continue its active support of individualized and innovative therapies and the transition of novel treatments for aggressive thyroid cancers and immunologic diseases to clinical practice. Dr. Smallridge also emphasizes the importance of promoting thyroid-related health issues such as global iodine nutrition and improved availability of prophylactic potassium iodide. He recognizes that the future growth and health of the ATA depends on continued recruitment of young physicians and investigators from a variety of disciplines and intends to dedicate time and effort to develop innovative approaches to reaching out to these individuals and making them feel part of the organization.

Dr. Hollenberg is Chief of the Division of Endocrinology, Diabetes and Metabolism at the Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School, Boston, MA. He directs the Clinical Investigator Training Program at Harvard Medical School, a two-year Master’s program for physician-scientists interested in careers in translational medicine. Dr. Hollenberg’s research focuses on understanding the biology of thyroid hormone action, and his laboratory is studying new biomarkers that could improve patient care. He has served on the Education Committee and the Program Committee of the ATA and is currently Chair of the Publications Committee.

Dr. Jonklaas is Associate Professor, Endocrinology Division at Georgetown University, Washington, DC. She divides her time equally between patient care, research, and teaching. The primary focus of her research is the management of thyroid cancer and hypothyroidism. Dr. Jonklaas has served on several ATA committees including Patient Education and Advocacy, the Surgical Task Force, and the Awards Committee. She is currently Co-Chair of the Task Force on Thyroid Hormone Replacement.

“These three renowned thyroidologists are leaders in our field and have already served ATA in many important roles,” says John C. Morris, III, M.D., Secretary and Chief Operating Officer of the ATA, and Professor of Medicine, Mayo Clinic College of Medicine, Rochester, MN. “We are excited to have such experienced leaders join our Board and bring their wealth of knowledge and skills to our leadership team.”

About the ATA

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,700 members from 43 countries around the world. Celebrating its 90th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology (CT), VideoEndocrinology and CT for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs through; and the development of guidelines for clinical management of thyroid disease. Visit for more information.

Media Contact
Bobbi Smith
Executive Director of the American Thyroid Association